← SynDRA
SF-11
SynDRA canonical compound SYN0062926 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | MCOLN3 | NPY2R |
| Mechanism of action | neuropeptide receptor antagonist |
All known targets
Mechanisms of action (all sources)
- NPY2R ANTAGONIST
- neuropeptide receptor antagonist
- MCOLN3 ACTIVATOR
Cross-references
Synonyms
- ML075
- SF 11
- SF11
- TCMDC-124500
- MLS001111122
- SMR000457056
- 3-(4-chlorophenyl)-5-methyl-4-[2-(4-methylphenyl)sulfonylpyrazol-3-yl]-1,2-oxazole
- 3-(4-chlorophenyl)-5-methyl-4-{1-[(4-methylphenyl)sulfonyl]-1H-pyrazol-5-yl}isoxazole
- SR-01000768170
- AC1MCJZ0
- CHEMBL548708
- GTPL6404
- cid_2745583
- BDBM46991
- HMS1669J02
- SR-01000768170-4
- SR-01000768170-3
- SR-01000768170-2
- 3-(4-chlorophenyl)-5-methyl-4-(2-tosylpyrazol-3-yl)isoxazole
- MLS000569101
- SMR000177227
- SR-01000496056
- Oprea1_641933
- orb1704069
- SCHEMBL15919884
- BDBM42539
- C27H30N2O2S
- CHEBI:92750
- cid_2936384
- GTPL14159
- REGID_for_CID_2936384
- GLXC-02705
- HMS2560N17
- TSA29281
- MFCD03032390
- STK077599
- AKOS000589821
- ML075 (SF-11)
- EBC-316059
Look up SF-11 in the interactive SynDRA portal →